October is #LiverCancerAwarenessMonth. Recently activated - NRG-GI012 (HELIO-RT) will be testing if adding SBRT to immunotherapy improves survival compared to IO-based systemic therapy alone, in patients with advanced primary liver cancer, or hepatocellular cancer.
17 days ago